Tumor-Induced Osteomalacia.
作者信息
Kumar Rajiv, Folpe Andrew L, Mullan Brian P
机构信息
Division of Nephrology and Hypertension, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905 ; Division of Endocrinology, Metabolism, Diabetes and Nutrition, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905 ; Department of Internal Medicine, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905 ; Department of Biochemistry and Molecular Biology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905.
Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street Southwest, Rochester, MN 55905.
出版信息
Transl Endocrinol Metab. 2015 Summer;7(3).
Abstract
摘要
相似文献
1
Tumor-Induced Osteomalacia.
Transl Endocrinol Metab. 2015 Summer;7(3).
2
Phosphaturic Mesenchymal Tumors from Head to Toe: Imaging Findings and Role of the Radiologist in Diagnosing Tumor-Induced Osteomalacia.
Indian J Orthop. 2020 Jan 13;54(2):215-223. doi: 10.1007/s43465-019-00005-5. eCollection 2020 Apr.
3
Tumor-induced osteomalacia.
Curr Opin Rheumatol. 1994 May;6(3):340-4. doi: 10.1097/00002281-199405000-00017.
4
Evaluation of tumor-induced osteomalacia with 111In-pentetreotide scintigraphy.
J Nucl Med Technol. 2013 Dec;41(4):299-301. doi: 10.2967/jnmt.113.126763. Epub 2013 Oct 24.
5
Burosumab in tumor-induced osteomalacia: A case report.
Joint Bone Spine. 2020 Jan;87(1):81-83. doi: 10.1016/j.jbspin.2019.07.012. Epub 2019 Aug 3.
6
Tumor-induced osteomalacia and symptomatic looser zones secondary to mesenchymal chondrosarcoma.
J Surg Oncol. 1999 May;71(1):58-62. doi: 10.1002/(sici)1096-9098(199905)71:1<58::aid-jso12>3.0.co;2-f.
7
Oncogenic osteomalacia associated with mesenchymal tumor in the middle cranial fossa: a case report.
J Med Case Rep. 2012 Jul 2;6:181. doi: 10.1186/1752-1947-6-181.
8
Successful treatment of tumor-induced osteomalacia causing by phosphaturic mesenchymal tumor of the foot.
Medicine (Baltimore). 2019 Jul;98(27):e16296. doi: 10.1097/MD.0000000000016296.
9
Hypophosphatemic osteomalacia: association with prostatic carcinoma.
Ann Intern Med. 1980 Aug;93(2):275-8. doi: 10.7326/0003-4819-93-2-275.
10
[Tumor-induced osteomalacia caused by a late-revealing phosphaturic mesenchymal tumor].
Rev Med Interne. 2017 Jun;38(6):412-415. doi: 10.1016/j.revmed.2016.08.020. Epub 2016 Sep 19.
引用本文的文献
1
A case report of Tumor-Induced Osteomalacia (TIO) caused by central giant cell granuloma.
Bone Rep. 2024 Sep 10;22:101804. doi: 10.1016/j.bonr.2024.101804. eCollection 2024 Sep.
2
Unusual presentation of tumor-induced osteomalacia mismanaged due to misdiagnosis: A literature review based on a case report.
Clin Case Rep. 2024 May 20;12(5):e8885. doi: 10.1002/ccr3.8885. eCollection 2024 May.
3
Tumor-induced osteomalacia characterized by "painful knee joint with difficulty in moving": a case report.
BMC Endocr Disord. 2022 Jul 8;22(1):174. doi: 10.1186/s12902-022-01078-4.
4
A rare combination of tumor-induced osteomalacia caused by sinonasal glomangiopericytoma and coexisting parathyroid adenoma: case report and literature review.
BMC Endocr Disord. 2022 Jan 28;22(1):31. doi: 10.1186/s12902-022-00934-7.
5
Tumor-induced osteomalacia: a case report.
J Med Case Rep. 2022 Jan 12;16(1):22. doi: 10.1186/s13256-021-03220-7.
6
Phosphaturic mesenchymal tumors: radiological aspects and suggested imaging pathway.
Radiol Med. 2021 Dec;126(12):1609-1618. doi: 10.1007/s11547-021-01412-1. Epub 2021 Aug 28.
7
Prolonged Hypophosphatemia and Intensive Care After Curative Surgery of Tumor Induced Osteomalacia: A Case Report.
Front Endocrinol (Lausanne). 2021 Jun 3;12:686135. doi: 10.3389/fendo.2021.686135. eCollection 2021.
8
Metastatic prostate cancer presenting as tumour-induced osteomalacia.
BMJ Case Rep. 2019 Jul 16;12(7):e229434. doi: 10.1136/bcr-2019-229434.
9
Tumor-induced osteomalacia with the culprit lesion located in the palm: a case report.
J Int Med Res. 2019 May;47(5):2240-2247. doi: 10.1177/0300060519833476. Epub 2019 Mar 12.
10
Tumor-induced osteomalacia.
Osteoporos Sarcopenia. 2018 Dec;4(4):119-127. doi: 10.1016/j.afos.2018.12.001. Epub 2018 Dec 12.
本文引用的文献
1
Frequent expression of fibroblast growth factor-23 (FGF23) mRNA in aneurysmal bone cysts and chondromyxoid fibromas.
J Clin Pathol. 2012 Oct;65(10):907-9. doi: 10.1136/jclinpath-2012-200852. Epub 2012 Aug 29.
2
Selective venous catheterization for the localization of phosphaturic mesenchymal tumors.
J Bone Miner Res. 2011 Jun;26(6):1295-302. doi: 10.1002/jbmr.316.
3
Parathyroid hormone levels in long-term renal transplant children and adolescents.
Pediatr Nephrol. 2011 Nov;26(11):2051-7. doi: 10.1007/s00467-011-1896-8. Epub 2011 May 10.
4
Phosphaturic mesenchymal tumor with chondromyxoid fibroma-like feature: an unusual morphological appearance.
Skeletal Radiol. 2011 Nov;40(11):1481-5. doi: 10.1007/s00256-011-1159-6. Epub 2011 May 1.
5
Tumor-induced osteomalacia.
Endocr Relat Cancer. 2011 Jun 8;18(3):R53-77. doi: 10.1530/ERC-11-0006. Print 2011 Jun.
6
Tumor-induced osteomalacia: a single center experience.
Endocr Pract. 2011 Mar-Apr;17(2):177-84. doi: 10.4158/EP10151.OR.
7
8
Sinonasal phosphaturic mesenchymal tumor (mixed connective tissue variant): report of 2 cases.
Am J Surg Pathol. 2010 Apr;34(4):596-7. doi: 10.1097/PAS.0b013e3181d594fa.
9
A novel nonsense mutation in the DMP1 gene in a Japanese family with autosomal recessive hypophosphatemic rickets.
J Bone Miner Metab. 2010 Sep;28(5):585-90. doi: 10.1007/s00774-010-0169-0. Epub 2010 Mar 9.
10
A 9-month-old phosphaturic mesenchymal tumor mimicking the intractable rickets.
J Pediatr Orthop B. 2010 Jan;19(1):127-32. doi: 10.1097/BPB.0b013e32832f59cb.
Zotero 插件